Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

Thanks,Chemist. What a great read! Here's a part I really liked, "Until researchers get better at predicting which neoantigens will generate a response, they need to target cancers with a high mutation rate, says Fred Ramsdell, vice-president of research at the non-profit Parker Institute for Cancer Immunotherapy in San Francisco, California. As well as melanoma, that category includes lung, stomach, colorectal and cervical cancers. “We want to be really efficient in generating these responses before we go to tumours with a mutation load that’s relatively low,” Ramsdell says."

NEO is targeting metastatic micro-satellite stable colon cancer,
metastatic squamous histology head and neck cancer and metastatic non-small cell lung cancer.

This could bode well for us.